Dr Sabine Hazan Steinberg has over 22 years of experience in clinical trials and is the Founder and CEO at both Ventura Clinical Trials and Malibu Specialty Center.
MILAN and MALIBU, Calif., Nov. 21, 2019 /PRNewswire/ — Progenabiome’s Jordan Daniels is slated to present a Case Study of metastatic mesothelioma treated with Fecal Microbiota Transplant (FMT) as adjunctive therapy to Pembrolizumab. For years, Progenabiome’s CEO Dr. Sabine Hazan-Steinberg, has used FMT to treat patients with Clostridioides Difficile (C.diff) using
Progenabiome, a genetic sequencing laboratory of the gut flora. Leading the way into the FUTURE by understanding the microbiome NOW. The quest for a new healthcare revolution! “This data will change healthcare and make us more aware of our gut microbiome,” said Dr. Sabine Hazan-Steinberg, CEO and Founder of Progenabiome. “2500
Can Fecal Microbiota Transplant (FMT) Aid in Cancer Treatment? PRESS RELEASE PR Newswire Nov. 21, 2019, 04:45 PM MILAN and MALIBU, Calif., Nov. 21, 2019 /PRNewswire/ — Progenabiome’s Jordan Daniels is slated to present a Case Study of metastatic mesothelioma treated with Fecal Microbiota Transplant (FMT) as adjunctive therapy to Pembrolizumab.
Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments Progenabiome plans for continued discussions at Malibu Microbiome Meeting in March 2020 News provided by Progenabiome MALIBU, Calif., Nov. 13, 2019 /PRNewswire/ — Several doctors spoke before the FDA in Washington D.C. on November 4, advocating for C.diff treatment
Sabine Hazan, M.D., is a local gastroenterologist and CEO of Progenabiome and Ventura Clinical Trials. Hazan offers the following information and advice. Are you aware of any cases of the coronavirus among your Malibu patients? Not in Malibu but Ventura, where I am also based, had
By Sabine Hazan, MD |March 19, 2020 “In a war against bugs the medical doctors are the soldiers”. Dr. Sabine Hazan Novel coronavirus, officially known as COVID-19, has now been declared a global pandemic. Originating in bats in the city of Wuhan, China, the virus attacks the lungs, causing fevers,
Pictured: Dr. Sabine Hazan (standing) and Dr. Brad Barrows, a pathologist on her team at Progenobiome. Photo by Dr. Chris Gilbert. by Kimberly Rivers [email protected] On Monday, three proposals for clinical trials related to combatting novel coronavirus and COVID-19 were sent to the Institutional Review Board for approval by a
By Chris Gilbert, MD, PhD |April 16, 2020 Understanding the Power of Poop: The linkage between gut health and overall health has been recognized since the days of Hippocrates. Learn how healthy gut bacteria is being used to treat conditions today and potential future applications. We are always looking for
MALIBU, Calif., May 4, 2020 /PRNewswire/ — Progenabiome is sharing gut microbiome research findings by next generation shotgun sequencing utilizing Kraken metagenomic analysis at the Digestive Disease Week (DDW) 2020 virtual meeting May 2-5. The California-based research lab was scheduled to present at DDW, the world’s largest gathering of digestive disease
Globalization, which is the fusing of disparatetrade agreements, communications,economies, technologies, and cultures,1 hassignificantly changed humans’ environments, diets,and overall health. The term “globesity” refersto the shift from traditional, localized diets to aWestern diet, known as “nutrition transition.”2Research has shown that increasing globalizationby one standard deviation often results in a 23.8%increase in